All things aside SEC May 1st deadline fast approaching!

New Post Public Reply Private Reply Replies (0) Message Board
subflyer8
All things aside SEC May 1st deadline fast approaching!

http://www.reuters.com/article/2014/03/26/otc...5Y20140326

Quote:
(Reuters) - OTC Markets, the operator of three U.S. over-the-counter equity markets, is rolling out tighter reporting standards and eligibility requirements for its venture-stage market to crack down on stock scams and bolster transparency, the company said on Wednesday.

OTC Markets will introduce a new minimum 1 cent bid price requirement on May 1 for its OTCQB market and will require the company's chief executive or chief financial officer to certify that its reporting obligations are current and that disclosures about shareholdings, officers and corporate profile are correct.

The bid requirement, in which stocks must have been quoted for at least 1 cent daily over a 30-day period or be dropped from the market, aims to ferret out companies that fall prey to dilutive stock fraud schemes and promotions, OTC Markets said.

Greater scrutiny of management, directors and shareholders would help reduce fraud in micro-cap stocks, which has been a focus of the Securities and Exchange Commission, according to Cromwell Coulson, president and chief executive of OTC Markets.

Even companies that are current in reporting information to the SEC can be problematic, Coulson said. In 2012, the SEC ordered 10-day suspensions of 672 micro-cap and shell securities, just 16 of which were current in their reporting.

Yet the 16 securities accounted for nearly 80 percent of the total dollar volume of all suspended securities in the 90 days prior to their suspension, Coulson said in congressional testimony last year.

OTC Markets also will charge a one-time $2,500 fee for new applicants and an annual $10,000 fee for companies trading on the OTCQB market.

Foreign companies that are listed on a qualified stock exchange and are current in their U.S. reporting obligations will be allowed to trade on OTCQB, OTC Markets' middle-tier marketplace. In the past, they traded on the lowest "pink" tier.

On Tuesday, the two most actively traded stocks on OTC Markets were French dairy products maker Danone SA and Swiss pharmaceuticals Roche Holding AG.

Trading volume on OTC Markets was 20.1 billion shares on Tuesday, about three times that of all U.S. stock exchanges and other trading venues. But the value traded, $1.4 billion, paled in comparison with the $263.4 billion executed on the other exchanges and venues, data from BATS Global Markets showed. (Reporting by Herbert Lash; Editing by Leslie Adler)


I believe they wont R/S for this reason i believe ACLP to trade .01+ within the next couple weeks!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 283

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 240

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 243

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 235

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 251

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 164

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Electric Vehicle Production with Smart Technology

Updated Category News Views 153

Rockwell Automation Enhances Lucid's EV Manufacturing Rockwell Automation, Inc. (NYSE: ROK), renowned for its commitment to industrial automation and digital transformation, is set to significantly enhance the electric vehicle (EV) production capabilities for Lucid. This collaboration aligns with Saudi Arabia's Vision 2030, aiming to develop a sustainable and diversified...

Continue Reading
TeraWulf Inc. Seeks Growth with Convertible Notes and Google Deal

Updated Category News Views 158

TeraWulf Stock Overview TeraWulf Inc. (NASDAQ: WULF) is observing fluctuations in its stock value amidst significant financial developments. The company's stock experienced a minor drop of 0.96%, settling at $9.29 in pre-market trading. Investors are closely monitoring the implications of recent announcements on the company's future Convertible Notes Offering Details...

Continue Reading
Kaltura's Growth Prospects and Strategic Insights Explored

Updated Category News Views 301

Kaltura got analysts buzzing back in 2024 with their second-quarter results that had the desks reeling. Adjusted EBITDA hit $1.6 million when everyone was just hoping for $0.2 million. Revenue? $44 million, up from the expected $43.1 million—these numbers showed Kaltura wasn’t just treading water; they were swimming against the tide. Kaltura's Performance Metrics: A...

Continue Reading
Nvidia's Unprecedented Market Influence in the AI Era

Updated Category News Views 139

Nvidia's Rise as a Technological Powerhouse Nvidia Corporation (NASDAQ: NVDA) has reached a new peak in its market valuation, crossing a staggering $4 trillion. Investors have welcomed the recent news regarding the resumption of sales of its advanced AI chips, boosting trust in the company's future prospects. This surge heightens interest in Nvidia, showcasing a potential...

Continue Reading
Global Oil Prices Drop Amid Trade Tensions and Demand Concerns

Updated Category News Views 392

Oil Prices Facing Declines Recent trends indicate that oil prices have been on a downward trajectory, particularly influenced by uncertainties surrounding geopolitical tensions and tariffs imposed by the U.S. However, a critical observation is that these factors intertwine to significantly affect global economic conditions and energy demand. Current Status of Oil Pricing...

Continue Reading